{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:33:09Z","timestamp":1793910789795,"version":"4.8.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kutahya University of Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prostate cancer (PCa) diagnosis relies heavily on PSA screening, which suffers from low specificity, leading to unnecessary biopsies and overdiagnosis. Distinguishing PCa from benign prostatic hyperplasia (BPH) remains a significant clinical challenge. Extracellular vesicles (EVs) protect molecular cargo, such as microRNAs (miRNAs), from degradation and reflect the physiological state of their parental cells. Given their stability and accessibility in biological fluids, EV-associated miRNAs represent ideal liquid biopsy candidates to overcome the limitations of current diagnostic markers and improve risk stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study investigated the potential of a specific plasma EV-derived miRNA panel (miR-16, miR-141, miR-10b, miR-373, miR-409, miR-34a, miR-205, miR-145, and miR-550a) to differentiate between healthy controls, BPH, localized PCa (LPCa), and metastatic PCa (MPCa).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Plasma EVs were isolated using a precipitation-based method, followed by total RNA extraction. EV-derived miRNA expression profiles were quantified via qRT-PCR. Statistical analyses were performed to compare expression levels across clinical groups and to assess their diagnostic potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Significant differential expression was observed for EV-derived miR-141, miR-10b, and miR-550a. miR-141 was significantly downregulated in BPH and LPCa compared to healthy controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Notably, EV-derived miR-10b and miR-550a levels were significantly lower in the MPCa group compared to BPH. When comparing all PCa cases (LPCa+MPCa) against non-cancerous groups (BPH+Control), EV-derived miR-10b and miR-550a were significantly downregulated, while miR-16 showed upregulation in the cancer cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings demonstrate that specific plasma EV-derived miRNA signatures can distinguish prostate pathologies and disease stages. These results suggest that EV-derived miR-10b, miR-141, miR-16 and miR-550a hold promise as non-invasive biomarkers for differentiating PCa from BPH, potentially reducing overdiagnosis and informing clinical management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11845-026-04482-0","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:28:53Z","timestamp":1781231333000},"page":"2643-2653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extracellular vesicle\u2013derived miR-141, miR-10b, miR-550a and miR-16 define a circulating signature in prostate cancer"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2179-1318","authenticated-orcid":false,"given":"Emine","family":"Yagci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2433-9925","authenticated-orcid":false,"given":"Hulyam","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0890-486X","authenticated-orcid":false,"given":"Ata","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1120-1874","authenticated-orcid":false,"given":"Cansu","family":"Ozbayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5002-5041","authenticated-orcid":false,"given":"Selma","family":"Metintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"3","key":"4482_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41416-021-01610-8","volume":"126","author":"M Ramirez-Garrastacho","year":"2021","unstructured":"Ramirez-Garrastacho M, Bajo-Santos C, Line A et al (2021) Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: A decade of research. Br J Cancer 126(3):331\u2013350. https:\/\/doi.org\/10.1038\/s41416-021-01610-8","journal-title":"Br J Cancer"},{"issue":"06","key":"4482_CR2","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1590\/S1677-5538.IBJU.2015.0690","volume":"42","author":"RR Tourinho-Barbosa","year":"2016","unstructured":"Tourinho-Barbosa RR, Pompeo ACL, Glina S (2016) Prostate cancer in Brazil and Latin America: epidemiology and screening. Int Braz J Urol 42(06):1081\u20131090. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2015.0690","journal-title":"Int Braz J Urol"},{"key":"4482_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.bioactmat.2021.08.029","volume":"10","author":"A Thakur","year":"2022","unstructured":"Thakur A, Parra DC, Motallebnejad P et al (2022) Exosomes: Small vesicles with big roles in cancer, vaccine development, and therapeutics. Bioact Mater 10:281\u2013294. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.08.029","journal-title":"Bioact Mater"},{"issue":"10","key":"4482_CR4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/1535370218775657","volume":"243","author":"AA Moustafa","year":"2018","unstructured":"Moustafa AA, Kim H, Albeltagy RS et al (2018) MicroRNAs in prostate cancer: From function to biomarker discovery. Exp Biol Med (Maywood) 243(10):817\u2013825. https:\/\/doi.org\/10.1177\/1535370218775657","journal-title":"Exp Biol Med (Maywood)"},{"issue":"5","key":"4482_CR5","doi-asserted-by":"publisher","first-page":"702","DOI":"10.17305\/bb.2025.12971","volume":"26","author":"E Volar","year":"2025","unstructured":"Volar E, Vukovi\u0107 B, Franin I et al (2025) Circulating microRNAs in prostate cancer-Non-invasive biomarkers for diagnosis, prognosis and therapy: A review. Biomol Biomed 26(5):702\u2013710. https:\/\/doi.org\/10.17305\/bb.2025.12971","journal-title":"Biomol Biomed"},{"key":"4482_CR6","doi-asserted-by":"publisher","first-page":"1065757","DOI":"10.3389\/fgene.2023.1065757","volume":"14","author":"G Jain","year":"2023","unstructured":"Jain G, Das P, Ranjan P et al (2023) Urinary extracellular vesicles miRNA\u2014A new era of prostate cancer biomarkers. Front Genet 14:1065757. https:\/\/doi.org\/10.3389\/fgene.2023.1065757","journal-title":"Front Genet"},{"issue":"11","key":"4482_CR7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm.1880","volume":"14","author":"D Bonci","year":"2008","unstructured":"Bonci D, Coppola V, Musumeci M et al (2008) The miR-15a\u2013miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14(11):1271\u20131277. https:\/\/doi.org\/10.1038\/nm.1880","journal-title":"Nat Med"},{"issue":"6","key":"4482_CR8","doi-asserted-by":"publisher","first-page":"188809","DOI":"10.1016\/j.bbcan.2022.188809","volume":"1877","author":"N Chauhan","year":"2022","unstructured":"Chauhan N, Manojkumar A, Jaggi M et al (2022) MicroRNA-205 in prostate cancer: Overview to clinical translation. Biochim Biophys Acta Rev Cancer 1877(6):188809. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188809","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"3","key":"4482_CR9","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41416-021-01598-1","volume":"126","author":"M Ramirez-Garrastacho","year":"2021","unstructured":"Ramirez-Garrastacho M, Berge V, Lin\u0113 A et al (2021) Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients. Br J Cancer 126(3):492\u2013501. https:\/\/doi.org\/10.1038\/s41416-021-01598-1","journal-title":"Br J Cancer"},{"key":"4482_CR10","doi-asserted-by":"publisher","first-page":"101613","DOI":"10.1016\/j.tranon.2022.101613","volume":"28","author":"F Ghamlouche","year":"2023","unstructured":"Ghamlouche F, Yehya A, Zeid Y et al (2023) MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer. Transl Oncol 28:101613. https:\/\/doi.org\/10.1016\/j.tranon.2022.101613","journal-title":"Transl Oncol"},{"key":"4482_CR11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/978-3-032-08824-6_15","volume-title":"MicroRNAs: Role in Cancer Progression, Diagnostics and Therapy","author":"P Goel","year":"2026","unstructured":"Goel P, Mandal CC (2026) MicroRNAs for the Treatment and Diagnosis of Cancer in Bone Metastasis. MicroRNAs: Role in Cancer Progression, Diagnostics and Therapy. Springer Nature Switzerland, Cham, pp 323\u2013341"},{"issue":"16","key":"4482_CR12","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.3390\/cancers15164027","volume":"15","author":"AN Prigol","year":"2023","unstructured":"Prigol AN, Rode MP, da Luz Efe F et al (2023) The bone microenvironment soil in prostate cancer metastasis: an miRNA approach. Cancers 15(16):4027. https:\/\/doi.org\/10.3390\/cancers15164027","journal-title":"Cancers"},{"issue":"12","key":"4482_CR13","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.3390\/ijms21124507","volume":"21","author":"BY Shorning","year":"2020","unstructured":"Shorning BY, Dass MS, Smalley MJ et al (2020) The PI3K-AKT-mTOR pathway and prostate cancer: at the crossroads of AR, MAPK, and WNT signaling. Int J Mol Sci 21(12):4507. https:\/\/doi.org\/10.3390\/ijms21124507","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4482_CR14","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.3390\/ijms24043688","volume":"24","author":"JP Shiau","year":"2023","unstructured":"Shiau JP, Chuang YT, Yen CY et al (2023) Modulation of AKT pathway-targeting miRNAs for cancer cell treatment with natural products. Int J Mol Sci 24(4):3688. https:\/\/doi.org\/10.3390\/ijms24043688","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4482_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/0300060515576556","volume":"44","author":"Y Mao","year":"2016","unstructured":"Mao Y, Wu S, Zhao R et al (2016) MiR-205 promotes proliferation, migration and invasion of nasopharyngeal carcinoma cells by activation of AKT signalling. J Int Med Res 44(2):231\u2013240. https:\/\/doi.org\/10.1177\/0300060515576556","journal-title":"J Int Med Res"},{"issue":"3","key":"4482_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1515\/cmble-2015-0025","volume":"20","author":"MR Fomeshi","year":"2015","unstructured":"Fomeshi MR, Ebrahimi M, Mowla SJ et al (2015) Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells. Cell Mol Biology Lett 20(3):448\u2013465. https:\/\/doi.org\/10.1515\/cmble-2015-0025","journal-title":"Cell Mol Biology Lett"},{"issue":"4","key":"4482_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2013\u2206\u2206CT method. Methods 25(4):402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"3","key":"4482_CR18","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3892\/or.2020.7682","volume":"44","author":"F Wang","year":"2020","unstructured":"Wang F, Wang W, Lu L et al (2020) MicroRNA-16-5p regulates cell survival, cell cycle and apoptosis by targeting AKT3 in prostate cancer cells. Oncol Rep 44(3):1282\u20131292. https:\/\/doi.org\/10.3892\/or.2020.7682","journal-title":"Oncol Rep"},{"issue":"4","key":"4482_CR19","doi-asserted-by":"publisher","first-page":"e42733","DOI":"10.1016\/j.heliyon.2025.e42733","volume":"11","author":"Z Sadeghi","year":"2025","unstructured":"Sadeghi Z, Malekzadeh M, Sharifi M et al (2025) The role of miR-16 and miR-34a family in the regulation of cancers: A review. Heliyon 11(4):e42733. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42733","journal-title":"Heliyon"},{"issue":"3","key":"4482_CR20","doi-asserted-by":"publisher","first-page":"839","DOI":"10.5114\/aoms.2020.95653","volume":"20","author":"Y Yang","year":"2020","unstructured":"Yang Y, Zhao F (2020) MicroRNA-16 inhibits the growth and metastasis of human glioma cells via modulation of PI3K\/AKT\/mTOR signalling pathway. Arch Med Sci 20(3):839. https:\/\/doi.org\/10.5114\/aoms.2020.95653","journal-title":"Arch Med Sci"},{"key":"4482_CR21","doi-asserted-by":"publisher","first-page":"9291","DOI":"10.2147\/IJN.S503954","volume":"20","author":"WH Weng","year":"2025","unstructured":"Weng WH, Chiou YE, Zeng WZ et al (2025) Hsa-miRNA-16-5p of urinary exosomes a reliable biosignature effective for prostate cancer screening. Int J Nanomed 20:9291\u20139300. https:\/\/doi.org\/10.2147\/IJN.S503954","journal-title":"Int J Nanomed"},{"issue":"4","key":"4482_CR22","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.bbrc.2016.12.045","volume":"482","author":"JZ Li","year":"2017","unstructured":"Li JZ, Li J, Wang HQ et al (2017) MiR-141-3p promotes prostate cancer cell proliferation through inhibiting kruppel-like factor-9 expression. Biochem Biophys Res Commun 482(4):1381\u20131386. https:\/\/doi.org\/10.1016\/j.bbrc.2016.12.045","journal-title":"Biochem Biophys Res Commun"},{"issue":"55","key":"4482_CR23","doi-asserted-by":"publisher","first-page":"94834","DOI":"10.18632\/oncotarget.22014","volume":"8","author":"Y Ye","year":"2017","unstructured":"Ye Y, Li SL, Ma YY et al (2017) Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer. Oncotarget 8(55):94834\u201394846. https:\/\/doi.org\/10.18632\/oncotarget.22014","journal-title":"Oncotarget"},{"issue":"1","key":"4482_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13046-017-0645-7","volume":"36","author":"S Huang","year":"2017","unstructured":"Huang S, Wa Q, Pan J et al (2017) Downregulation of miR-141-3p promotes bone metastasis via activating NF-\u03baB signaling in prostate cancer. J Exp Clin Cancer Res 36(1):173. https:\/\/doi.org\/10.1186\/s13046-017-0645-7","journal-title":"J Exp Clin Cancer Res"},{"issue":"22","key":"4482_CR25","doi-asserted-by":"publisher","first-page":"14910","DOI":"10.1074\/jbc.C800074200","volume":"283","author":"M Korpal","year":"2008","unstructured":"Korpal M, Lee ES, Hu G et al (2008) The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283(22):14910\u201314914. https:\/\/doi.org\/10.1074\/jbc.C800074200","journal-title":"J Biol Chem"},{"issue":"9","key":"4482_CR26","first-page":"1674","volume":"8","author":"P Sheedy","year":"2018","unstructured":"Sheedy P, Medarova Z (2018) The fundamental role of miR-10b in metastatic cancer. Am J Cancer Res 8(9):1674","journal-title":"Am J Cancer Res"},{"issue":"5","key":"4482_CR27","doi-asserted-by":"publisher","first-page":"648","DOI":"10.15252\/embr.201540678","volume":"17","author":"I Bahena-Ocampo","year":"2016","unstructured":"Bahena-Ocampo I, Espinosa M, Ceballos\u2010Cancino G et al (2016) miR\u201010b expression in breast cancer stem cells supports self\u2010renewal through negative PTEN regulation and sustained AKT activation. EMBO Rep 17(5):648\u2013658. https:\/\/doi.org\/10.15252\/embr.201540678","journal-title":"EMBO Rep"},{"issue":"10","key":"4482_CR28","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1002\/cam4.789","volume":"5","author":"H Jiang","year":"2016","unstructured":"Jiang H, Liu J, Chen Y et al (2016) Up-regulation of mir\u201010b predicate advanced clinicopathological features and liver metastasis in colorectal cancer. Cancer Med 5(10):2932\u20132941. https:\/\/doi.org\/10.1002\/cam4.789","journal-title":"Cancer Med"},{"issue":"3","key":"4482_CR29","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3892\/or.2015.3737","volume":"33","author":"YF Wang","year":"2015","unstructured":"Wang YF, Li Z, Zhao XH et al (2015) MicroRNA-10b is upregulated and has an invasive role in colorectal cancer through enhanced Rhoc expression. Oncol Rep 33(3):1275\u20131283. https:\/\/doi.org\/10.3892\/or.2015.3737","journal-title":"Oncol Rep"},{"issue":"4","key":"4482_CR30","first-page":"311","volume":"13","author":"P Vychytilova-Faltejskova","year":"2016","unstructured":"Vychytilova-Faltejskova P, Pesta M, Radova L et al (2016) Genome-wide microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer. Cancer Genomics Proteom 13(4):311\u2013316","journal-title":"Cancer Genomics Proteom"},{"issue":"11\u201312","key":"4482_CR31","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.bbagrm.2012.08.016","volume":"1819","author":"NP Hessvik","year":"2012","unstructured":"Hessvik NP, Phuyal S, Brech A et al (2012) Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells. Biochim Biophys Acta Gene Regul Mech 1819(11\u201312):1154\u20131163. https:\/\/doi.org\/10.1016\/j.bbagrm.2012.08.016","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"4","key":"4482_CR32","first-page":"361","volume":"2","author":"K Yang","year":"2009","unstructured":"Yang K, Handorean AM, Iczkowski KA (2008) MicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro. Int J Clin Exp Pathol 2(4):361\u2013369","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"4482_CR33","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3892\/ol.2013.1534","volume":"6","author":"X Zhang","year":"2013","unstructured":"Zhang X, Li X, Tan Z et al (2013) MicroRNA 373 is upregulated and targets TNFAIP1 in human gastric cancer, contributing to tumorigenesis. Oncol Lett 6(5):1427\u20131434. https:\/\/doi.org\/10.3892\/ol.2013.1534","journal-title":"Oncol Lett"},{"issue":"2","key":"4482_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ncb1681","volume":"10","author":"Q Huang","year":"2008","unstructured":"Huang Q, Gumireddy K, Schrier M et al (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10(2):202\u2013210. https:\/\/doi.org\/10.1038\/ncb1681","journal-title":"Nat Cell Biol"},{"issue":"1","key":"4482_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12967-015-0523-z","volume":"13","author":"F Wei","year":"2015","unstructured":"Wei F, Cao C, Xu X et al (2015) Diverse functions of miR-373 in cancer. J Transl Med 13(1):162. https:\/\/doi.org\/10.1186\/s12967-015-0523-z","journal-title":"J Transl Med"},{"issue":"17","key":"4482_CR36","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.1158\/1078-0432.CCR-14-0305","volume":"20","author":"S Josson","year":"2014","unstructured":"Josson S, Gururajan M, Hu P et al (2014) miR-409-3p\/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer. Clin Cancer Res 20(17):4636\u20134646. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0305","journal-title":"Clin Cancer Res"},{"issue":"6","key":"4482_CR37","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.7150\/ijbs.40787","volume":"16","author":"Q Gao","year":"2020","unstructured":"Gao Q, Lei F, Zeng Q et al (2020) Functional passenger-strand miRNAs in exosomes derived from human colon cancer cells and their heterogeneous paracrine effects. Int J Biol Sci 16(6):1044\u20131058. https:\/\/doi.org\/10.7150\/ijbs.40787","journal-title":"Int J Biol Sci"},{"issue":"1","key":"4482_CR38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/pros.23714","volume":"79","author":"N Ghorbanmehr","year":"2019","unstructured":"Ghorbanmehr N, Gharbi S, Korsching E et al (2019) miR-21\u20105p, miR\u2010141\u20103p, and miR\u2010205\u20105p levels in urine\u2014promising biomarkers for the identification of prostate and bladder cancer. Prostate 79(1):88\u201395. https:\/\/doi.org\/10.1002\/pros.23714","journal-title":"Prostate"},{"issue":"6","key":"4482_CR39","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/1759-7714.14331","volume":"13","author":"YL Zhao","year":"2022","unstructured":"Zhao YL, Zhang JX, Yang JJ et al (2022) MiR-205\u20105p promotes lung cancer progression and is valuable for the diagnosis of lung cancer. Thorac Cancer 13(6):832\u2013843. https:\/\/doi.org\/10.1111\/1759-7714.14331","journal-title":"Thorac Cancer"},{"issue":"1","key":"4482_CR40","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s12032-013-0785-3","volume":"31","author":"L Tian","year":"2014","unstructured":"Tian L, Zhang J, Ge J et al (2014) MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma. Med Oncol 31(1):785. https:\/\/doi.org\/10.1007\/s12032-013-0785-3","journal-title":"Med Oncol"},{"key":"4482_CR41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ebiom.2018.09.006","volume":"36","author":"YY Li","year":"2018","unstructured":"Li YY, Tao YW, Gao S et al (2018) Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p. EbioMedicine 36:209\u2013220. https:\/\/doi.org\/10.1016\/j.ebiom.2018.09.006","journal-title":"EbioMedicine"},{"issue":"1","key":"4482_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12943-017-0726-4","volume":"2017","author":"M Rodr\u00edguez","year":"2017","unstructured":"Rodr\u00edguez M, Bajo-Santos C, Hessvik NP et al (2017) Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes. Mol Cancer 2017(1):156. https:\/\/doi.org\/10.1186\/s12943-017-0726-4","journal-title":"Mol Cancer"},{"issue":"10","key":"4482_CR43","doi-asserted-by":"publisher","first-page":"e3100","DOI":"10.1038\/cddis.2017.495","volume":"8","author":"E Slab\u00e1kov\u00e1","year":"2017","unstructured":"Slab\u00e1kov\u00e1 E, Culig Z, Rems\u00edk J et al (2017) Alternative mechanisms of miR-34a regulation in cancer. Cell Death Dis 8(10):e3100. https:\/\/doi.org\/10.1038\/cddis.2017.495","journal-title":"Cell Death Dis"},{"issue":"5","key":"4482_CR44","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson D, Van Allen EM, Wu YM et al (2015) Integrative clinical genomics of advanced prostate cancer. Cell 161(5):1215\u20131228. https:\/\/doi.org\/10.1016\/j.cell.2015.05.001","journal-title":"Cell"},{"issue":"17","key":"4482_CR45","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1089\/scd.2016.0093","volume":"25","author":"K Takahara","year":"2016","unstructured":"Takahara K, Li M, Inamoto T et al (2016) microRNA-145 mediates the inhibitory effect of adipose tissue-derived stromal cells on prostate cancer. Stem Cells Dev 25(17):1290\u20131298. https:\/\/doi.org\/10.1089\/scd.2016.0093","journal-title":"Stem Cells Dev"},{"issue":"33","key":"4482_CR46","doi-asserted-by":"publisher","first-page":"53853","DOI":"10.18632\/oncotarget.10793","volume":"7","author":"JY Ho","year":"2016","unstructured":"Ho JY, Hsu RJ, Wu CH et al (2016) Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis by increasing levels of ERK1 and 2. Oncotarget 7(33):53853\u201353868. https:\/\/doi.org\/10.18632\/oncotarget.10793","journal-title":"Oncotarget"},{"issue":"1","key":"4482_CR47","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s12935-021-02197-z","volume":"21","author":"L Wei","year":"2021","unstructured":"Wei L, Wang G, Yang C et al (2021) MicroRNA-550a-3-5p controls the brain metastasis of lung cancer by directly targeting YAP1. Cancer Cell Int 21(1):491. https:\/\/doi.org\/10.1186\/s12935-021-02197-z","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4482_CR48","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1038\/ncomms3980","volume":"4","author":"C Villarroya-Beltri","year":"2013","unstructured":"Villarroya-Beltri C, Guti\u00e9rrez-V\u00e1zquez C, S\u00e1nchez-Cabo F et al (2013) Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun 4(1):2980. https:\/\/doi.org\/10.1038\/ncomms3980","journal-title":"Nat Commun"},{"issue":"21","key":"4482_CR49","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1056\/NEJMcp1103642","volume":"365","author":"RM Hoffman","year":"2011","unstructured":"Hoffman RM (2011) Screening for prostate cancer. N Engl J Med 365(21):2013\u20132019. https:\/\/doi.org\/10.1056\/NEJMcp1103642","journal-title":"N Engl J Med"},{"issue":"10","key":"4482_CR50","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.5858\/arpa.2018-0901-SA","volume":"142","author":"JD Merker","year":"2018","unstructured":"Merker JD, Oxnard GR, Compton C et al (2018) Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review. Arch Pathol Lab Med 142(10):1242\u20131253. https:\/\/doi.org\/10.5858\/arpa.2018-0901-SA","journal-title":"Arch Pathol Lab Med"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-026-04482-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:03:02Z","timestamp":1793908982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-026-04482-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4482"],"URL":"https:\/\/doi.org\/10.1007\/s11845-026-04482-0","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Eski\u015fehir Osmangazi University Clinical Research Ethics Committee decisions numbered 2019\/42.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All individuals provided informed consent in the study in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article. The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}